Skip to main content

Table 3 Comparison of Age-Adjusted Prevalence Rates per 100,000 in the Base Population Based on VHA Data and VHA/CMS Data*

From: Prevalence and trends of selected urologic conditions for VA healthcare users

 

1999 Rates (95% CI)

 

VHA

VHA/CMS

% Change

Male reproductive health

   

   Erectile Dysfunction

1,996 (1,982 – 2,011)

2,669 (2,652 – 2,685)

34

   Peyronie's Disease

27 (26 – 29)

40 (38 – 42)

48

   Infertility

62 (59 – 64)

75 (72 – 78)

21

   Undescended Testis

4 (4 – 5)

7 (6 – 7)

75

Urethral diseases

   

   Hypospadias

5 (4 – 5)

8 (7 – 9)

60

   Stricture

244 (239 – 249)

439 (432 – 445)

80

Interstitial Cystitis

504 (497 – 511)

1,195 (1,184 – 1,206)

137

Prostatitis

579 (571 – 586)

1,254 (1,243 – 1,266)

117

Prostate cancer

2,843 (2,825 – 2,861)

5,226 (5,202 – 5,250)

84

Bladder Cancer

519 (511 – 526)

938 (928 – 948)

81

Kidney Cancer

131 (128 – 135)

217 (213 – 222)

66

Renal Mass

470 (463 – 477)

1,209 (1,198 – 1,220)

157

Testis cancer

40 (38 – 42)

51 (49 – 53)

28

 

2000 Rates (95% CI)

 

VHA

VHA/CMS

% Change

Male reproductive health

   

   Erectile Dysfunction

2,073 (2,059 – 2,088)

2,790 (2,773 – 2,807)

35

   Peyronie's Disease

26 (25 – 28)

40 (38 – 42)

54

   Infertility

62 (59 – 64)

75 (72 – 77)

21

   Undescended Testis

5 (4 – 5)

7 (6 – 7)

40

Urethral diseases

   

   Hypospadias

4 (3 – 5)

7 (6 – 8)

75

   Stricture

217 (212 – 222)

412 (406 – 418)

90

Interstitial Cystitis

504 (497 – 511)

1,256 (1,245 – 1,267)

149

Prostatitis

543 (536 – 551)

1,200 (1,189 – 1,211)

121

Prostate cancer

2,709 (2,692 – 2,727)

5,232 (5,208 – 5,256)

93

Bladder Cancer

467 (460 – 475)

926 (916 – 936)

98

Kidney Cancer

128 (125 – 132)

220 (215 – 224)

72

Renal Mass

462 (455 – 468)

1,317 (1,305 – 1,328)

185

Testis cancer

38 (36 – 40)

50 (47 – 52)

32

 

2001 Rates (95% CI)

 

VHA

VHA/CMS

% Change

Male reproductive health

   

   Erectile Dysfunction

2,071 (2,057 – 2,086)

2,805 (2,788 – 2,822)

35

   Peyronie's Disease

22 (20 – 23)

35 (33 – 37)

59

   Infertility

61 (58 – 63)

76 (73 – 79)

25

   Undescended Testis

4 (3 – 5)

7 (6 – 8)

75

Urethral diseases

   

   Hypospadias

4 (3 – 5)

7 (6 – 8)

75

   Stricture

186 (182 – 190)

387 (308 – 393)

108

Interstitial Cystitis

491 (484 – 498)

1,344 (1,332 – 1,355)

174

Prostatitis

502 (495 – 509)

1,204 (1,193 – 1,215)

140

Prostate cancer

2,611 (2,594 – 2,628)

5,373 (5,349 – 5,398)

106

Bladder Cancer

433 (426 – 440)

942 (932 – 952)

118

Kidney Cancer

122 (118 – 125)

227 (222 – 231)

86

Renal Mass

452 (445 – 458)

1,444 (1432 – 1,455)

219

Testis cancer

38 (36 – 40)

50 (48 – 52)

32

 

2002 Rates (95% CI)

 

VHA

VHA/CMS

% Change

Male reproductive health

   

   Erectile Dysfunction

2,083 (2,069 – 2,098)

2,884 (2,867 – 2,901)

38

   Peyronie's Disease

19 (18 – 21)

33 (31 – 35)

74

   Infertility

59 (56 – 61)

74 (72 – 77)

25

   Undescended Testis

3 (2 – 3)

5 (4 – 6)

67

Urethral diseases

   

   Hypospadias

4 (3 – 4)

7 (6 – 7)

75

   Stricture

166 (162 – 170)

383 (377 – 389)

131

Interstitial Cystitis

441 (435 – 448)

1,358 (1,347 – 1,370)

208

Prostatitis

442 (435 – 448)

1,128 (1,118 – 1,139)

155

Prostate cancer

2,505 (2,488 – 2,521)

5,434 (5,409 – 5,459)

117

Bladder Cancer

394 (387 – 400)

943 (933 – 953)

139

Kidney Cancer

118 (115 – 121)

233 (229 – 238)

97

Renal Mass

442 (436 – 449)

1,584 (1,571 – 1,596)

258

Testis cancer

35 (33 – 37)

47 (44 – 49)

34

  1. * VHA indicates prevalence rates based on VHA data alone; VHA/CMS, prevalence rates based on VHA and Medicare Data.